Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
All Products
Displaying products by catalog number (1900 - 1999)
| 0100 | 0200 | 0300 | 0400 | 0500 | 0600 | 0700 | 0800 | 0900 | 1000 |
|---|---|---|---|---|---|---|---|---|---|
| 1100 | 1200 | 1300 | 1400 | 1500 | 1600 | 1700 | 1800 | 1900 | 2000 |
| 2100 | 2200 | 2300 | 2400 | 2500 | 2600 | 2700 | 2800 | 2900 | 3000 |
| 3100 | 3200 | 3300 | 3400 | 3500 | 3600 | 3700 | 3800 | 3900 | 4000 |
| 4100 | 4200 | 4300 | 4400 | 4500 | 4600 | 4700 | 4800 |
Cat.No. |
Product Name / Activity |
| 1900 | [Ala107]-MBP (104-118) Protein kinase C inhibitor |
| 1901 | [Ala113]-MBP (104-118) Protein kinase C inhibitor |
| 1902 | [Ala92]-p16 (84-103) Cyclin-dependent kinase inhibitor |
| 1903 | Peptide F9 Inhibits laminin-mediated cell adhesion and migration |
| 1904 | PKA inhibitor fragment (6-22) amide Potent protein kinase A inhibitor |
| 1905 | VIP (6-28) (human, rat, porcine, bovine) VIP antagonist |
| 1906 | Atrial natriuretic factor (1-28) (human, porcine) Endogenous peptide regulating blood pressure |
| 1907 | Neuromedin N (rat, mouse, porcine, canine) Neurotensin-like peptide |
| 1908 | Neuromedin B (porcine) Mammalian bombesin-like peptide |
| 1909 | Neurotensin Endogenous neurotransmitter and endocrine modulator |
| 1910 | Oxytocin Involved in uterine contraction and lactation |
| 1911 | VIP (human, rat, mouse, rabbit, canine, porcine) Involved in neurotransmission, smooth muscle relaxation |
| 1912 | Atrial natriuretic factor (1-28) (rat) Endogenous peptide regulating blood pressure |
| 1913 | [D-Phe12]-Bombesin Bombesin receptor antagonist |
| 1914 | Eledoisin Potent tachykinin receptor ligand |
| 1915 | Kinetensin (human) Neurotensin-like peptide |
| 1916 | Litorin Amphibian bombesin-like peptide |
| 1917 | Neuromedin U (rat) Endogenous modulator of blood pressure and flow, gut ion transport, feeding and body temperature |
| 1918 | Secretin (human) Gastrointestinal peptide |
| 1919 | Secretin (rat) Gastrointestinal peptide |
| 1920 | Eledoisin-Related Peptide Tachykinin receptor ligand |
| 1921 | N-Formyl-Met-Leu-Phe Endogenous FPR1 agonist |
| 1922 | [D-Lys3]-GHRP-6 Ghrelin receptor antagonist |
| 1923 | pp60 c-src (521-533) (phosphorylated) Inhibits tyrosine kinase activity of pp60c-src and pp60v-src |
| 1926 | MLCK inhibitor peptide Myosin light chain kinase inhibitor |
| 1927 | N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu Phosphopeptide ligand for src SH2 domain |
| 1928 | Neuropeptide AF (human) Implicated in pain modulation, opioid function and metabolism |
| 1929 | Melanocyte stimulating hormone release inhibiting factor Inhibitor of α-MSH release; inhibits opioid effects in vivo |
| 1930 | N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide Phosphopeptide ligand for src SH2 domain |
| 1931 | G-Protein antagonist peptide Inhibits G protein activation by GPCRs |
| 1932 | U 46619 Potent, stable thromboxane A2 (TP) receptor agonist |
| 1933 | Exendin-4 Potent GLP-1 receptor agonist |
| 1935 | Caffeic acid-pYEEIE Phosphopeptide ligand for src SH2 domain |
| 1936 | Damnacanthal Potent, selective inhibitor of p56lck |
| 1937 | NSC 693868 Cdk inhibitor. Also inhibits GSK-3 |
| 1938 | Amyloid β-Peptide (1-43) (human) Amyloid β-protein fragment |
| 1939 | C14TKL-1 Endogenous NK1 agonist |
| 1941 | m-3M3FBS Phospholipase C activator |
| 1942 | o-3M3FBS Inactive analog of m-3M3FBS (Cat. No. 1941) |
| 1944 | Loratidine Peripheral H1 antagonist; antiallergic agent |
| 1946 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P Potent ghrelin receptor full inverse agonist. Also antagonist at other neuropeptide receptors. Anticancer in vitro |
| 1947 | PR 39 (porcine) IκBα inhibitor |
| 1949 | L-670,596 Potent, selective thromboxane A2/prostaglandin endoperoxide antagonist |
| 1950 | Gap 26 Gap junction blocker; inhibits smooth muscle contraction and IP3-mediated ATP release |
| 1952 | DCB Allosteric modulator at mGlu5 |
| 1953 | DMeOB Negative allosteric modulator at mGlu5 |
| 1954 | Antagonist G Broad spectrum neuropeptide receptor antagonist |
| 1955 | Ritanserin Potent 5-HT2 antagonist |
| 1956 | Bestatin Aminopeptidase inhibitor |
| 1957 | GR 79236 A1 agonist |
| 1960 | SB 334867 Selective non-peptide OX1 antagonist |
| 1961 | SB 258585 hydrochloride Potent, selective 5-HT6 antagonist |
| 1962 | SB 239063 Potent, selective p38 MAPK inhibitor; orally active |
| 1963 | SB 408124 Selective non-peptide OX1 antagonist |
| 1964 | Gossypol Proapoptotic; downregulates Bcl-2 and Bcl-XL |
| 1965 | Simvastatin HMG-CoA reductase inhibitor |
| 1966 | UCM 707 Potent anandamide transport inhibitor |
| 1967 | Ranitidine hydrochloride Selective H2 antagonist |
| 1968 | AS 19 Reported potent 5-HT7 agonist |
| 1969 | SL 327 Selective inhibitor of MEK1 and MEK2; brain penetrant |
| 1970 | Norketamine hydrochloride Potent, non-competitive NMDA antagonist |
| 1971 | (+)-Anabasine hydrochloride Neuronal nicotinic receptor agonist |
| 1972 | Tianeptine sodium salt Selective facilitator of 5-HT uptake; antidepressant |
| 1974 | SANT-1 Inhibitor of hedgehog (Hh) signaling; antagonizes smoothened activity |
| 1975 | 6-Iodonordihydrocapsaicin Potent, competitive vanilloid receptor antagonist |
| 1979 | L-803,087 trifluoroacetate Potent and selective sst4 agonist |
| 1980 | L-817,818 Potent and selective sst5 agonist |
| 1982 | Reboxetine mesylate Potent, selective noradrenalin uptake inhibitor; orally active |
| 1983 | 740 Y-P Cell-permeable PI 3-kinase activator |
| 1984 | Nogo-66 (1-40) Competitive antagonist for Nogo-66 receptor; promotes neuron regeneration |
| 1985 | PNU 142633 Highly selective 5-HT1D agonist |
| 1987 | Leptomycin B Inhibits nuclear export of proteins; antitumor |
| 1989 | c-JUN peptide Peptide inhibitor of JNK/c-Jun interaction |
| 1990 | (R,R)-THC Potent subtype-selective ligand; ERα agonist/ERβ antagonist |
| 1991 | MPP dihydrochloride Highly selective ERα antagonist |
| 1994 | ZK 93423 hydrochloride Potent benzodiazepine agonist |
| 1995 | Ro 19-4603 Benzodiazepine inverse agonist |
| 1996 | ZK 93426 hydrochloride Potent, competitive benzodiazepine antagonist |
| 1997 | Ro 15-4513 Benzodiazepine partial inverse agonist |
| 1998 | JMV 449 Potent neurotensin receptor agonist |
| 1999 | Linopirdine dihydrochloride KV7 (KCNQ) channel blocker |
Products Alphabetically by Name
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
|---|
[top]
Quick Order
Find multiple products by catalog number
New Product E-alerts
Sign up for email updates from Tocris
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.